The Journal of Immunology, Vol 147, Issue 12 4286-4292, Copyright © 1991 by American Association of Immunologists

ARTICLES

Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation- and glucocorticoid-induced death

R Iseki, M Mukai and M Iwata
Laboratory of Cellular Immunology, Mitsubishi Kasei Institute of Life Sciences, Tokyo, Japan.

Apoptotic death can be induced in T cell hybridomas by glucocorticoids or the stimulation via the TCR/CD3 complex. The two apoptotic processes are mutually antagonistic. We have previously proposed that positive selection of thymocytes for the formation of the T cell repertoire might be based on a similar mechanism. We analyzed the TCR/CD3-mediated signals essential for the regulation of apoptosis in T cell hybridomas. We suggest that both an increase in the intracellular Ca2+ level and an activation of protein kinase C are essential for the TCR/CD3-mediated apoptosis, because we obtained the following results: 1) either reduction of extracellular Ca2+ concentration or addition of a protein kinase inhibitor, 1-(5-isoquinolkinelsulfonyl)-2-methylpiperazine or N- (2-(methylamino)ethyl)-5-isoquinolinesulfonamide, inhibited anti-CD3- induced but not dexamethasone-induced DNA fragmentation. 2) The combination of ionomycin and PMA, but neither one alone nor the combination of ionomycin and cyclic nucleotide analogs, induced DNA fragmentation. On the contrary, we suggest that only an increase in the intracellular Ca2+ level is essential for the inhibition of glucocorticoid-induced apoptosis, because ionomycin alone as well as the combination of ionomycin and PMA inhibited dexamethasone- but not anti-CD3-induced DNA fragmentation.

This article has been cited by other articles:

				F. C. Mooren, D. Bloming, A. Lechtermann, M. M. Lerch, and K. Volker Lymphocyte apoptosis after exhaustive and moderate exercise J Appl Physiol, July 1, 2002; 93(1): 147 - 153. [Abstract] [Full Text] [PDF]

				R. Wang, L. Zhang, X. Zhang, J. Moreno, X. Luo, M. Tondravi, and Y. Shi Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-{{kappa}}B Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-{{alpha}} During T Cell Activation J. Immunol., February 1, 2001; 166(3): 1983 - 1990. [Abstract] [Full Text] [PDF]

				U. A. Hirt, F. Gantner, and M. Leist Phagocytosis of Nonapoptotic Cells Dying by Caspase- Independent Mechanisms J. Immunol., June 15, 2000; 164(12): 6520 - 6529. [Abstract] [Full Text] [PDF]

				Y. Takemoto, M. Furuta, M. Sato, M. Kubo, and Y. Hashimoto Isolation and characterization of a novel HS1 SH3 domain binding protein, HS1BP3 Int. Immunol., December 1, 1999; 11(12): 1957 - 1964. [Abstract] [Full Text] [PDF]

				W. Y. Almawi, D. A. Hess, and M. J. Rieder Significance of Enhanced Cytokine Receptor Expression by Glucocorticoids Blood, November 15, 1998; 92(10): 3979 - 3979. [Full Text] [PDF]

				A. Alam, M. Y. Braun, F. Hartgers, S. Lesage, L. Cohen, P. Hugo, F. Denis, and R.-P. Sekaly Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus J. Exp. Med., November 3, 1997; 186(9): 1503 - 1512. [Abstract] [Full Text] [PDF]

				M Iwata, Y Ohoka, T Kuwata, and A Asada Regulation of T cell apoptosis via T cell receptors and steroid receptors Stem Cells, November 1, 1996; 14(6): 632 - 641. [Abstract]

				J. Li and A. Eastman Apoptosis in an Interleukin-2-dependent Cytotoxic T Lymphocyte Cell Line Is Associated with Intracellular Acidification J. Biol. Chem., February 17, 1995; 270(7): 3203 - 3211. [Abstract] [Full Text] [PDF]

				S. C. Frasch, P. M. Henson, J. M. Kailey, D. A. Richter, M. S. Janes, V. A. Fadok, and D. L. Bratton Regulation of Phospholipid Scramblase Activity during Apoptosis and Cell Activation by Protein Kinase Cdelta J. Biol. Chem., July 21, 2000; 275(30): 23065 - 23073. [Abstract] [Full Text] [PDF]